Glycogen Storage Disease Type I
9 clinical trials · Condition
◉ Watch Glycogen Storage Disease Type I
| Record | Firm | Date |
|---|---|---|
| Anaplerotic Therapy Using Triheptanoin for Patients With Glycogen Storage Disease Type I (NCT03665636) | Areeg El-Gharbawy | 2020-10-16 |
| Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency (NCT04138251) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2019-06-20 |
| Early Check: Expanded Screening in Newborns (NCT03655223) | RTI International | 2018-10-15 |
| Biomarker for Glycogen Storage Diseases (BioGlycogen) (NCT02385162) | CENTOGENE GmbH Rostock | 2018-08-20 |
| The Use of Uncooked Sweet Manioc Starch to Treat Hepatic Glycogen Storage Diseases (NCT03871673) | Hospital de Clinicas de Porto Alegre | 2017-04-29 |
Track Glycogen Storage Disease Type I automatically
Every clearance here is in the API, with alerts when new ones post.